Delflex w Dextrose 2.5% in a plastic container is a parenteral nutrition solution. Information regarding specific discount cards for this product is not publicly available through general drug information sources.
How can I find out about potential discounts for Delflex w Dextrose 2.5%?
To inquire about potential discounts or patient assistance programs for Delflex w Dextrose 2.5%, you would typically:
* Ask your healthcare provider or pharmacist: They may be aware of manufacturer-sponsored programs or have access to discount cards.
* Contact the manufacturer directly: Companies that produce parenteral nutrition solutions often have patient support services or websites with information on cost-saving options.
What is Delflex w Dextrose 2.5% used for?
Delflex w Dextrose 2.5% is a component of parenteral nutrition, which is an intravenous method of feeding that bypasses the digestive system. It is used for individuals who cannot absorb nutrients adequately through their gastrointestinal tract due to medical conditions such as short bowel syndrome, intestinal obstruction, or severe malabsorption. The dextrose component provides a source of carbohydrates for energy.
Are there other dextrose concentrations available?
Yes, parenteral nutrition solutions come in various dextrose concentrations, typically ranging from 5% to 70%. The specific concentration used depends on the individual patient's caloric and metabolic needs.
Who manufactures Delflex products?
Information on the specific manufacturer of "Delflex w Dextrose 2.5% in plastic container" is not provided in the general product information. However, many companies specialize in producing parenteral nutrition solutions, including Baxter, Fresenius Kabi, and ICU Medical.
What are the risks associated with parenteral nutrition?
Parenteral nutrition, including solutions like Delflex w Dextrose 2.5%, carries potential risks. These can include infection at the catheter insertion site or in the bloodstream, metabolic imbalances (such as hyperglycemia or hypoglycemia), electrolyte disturbances, and organ damage. Close medical supervision is required for patients receiving parenteral nutrition.